https://insights.citeline.com/medtech-insight/conferences/lsi-panel-says-womens-health-breaks-out-of-bikini-box-as-new-business-models-catch-investors-eye-2Q3JY73ZLJHIHAMNHCCRUOWHLE/2026-04-03T22:36:20.191Zalways0.5https://insights.citeline.com/resizer/fyTL7zZJ4L61fT6Q_vX6PYlptEY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/TXSSKMYS4FENFDRPNTGVJC4EMM.jpeghttps://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/fda-releases-trove-of-data-on-use-of-real-world-evidence-in-device-clearances-C3UOVVSRDFA2LE6JYF3CPUHL3U/2026-04-03T21:57:46.289Zalways0.5https://insights.citeline.com/resizer/3a0RRL3W7Ia7RJZSPNqLZCkRjt4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7ZO65TOXFJENBDZDI5NS67YPJA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/vedantas-phase-iii-for-recurrent-c-diff-gets-nod-to-continue-TEP5SSBGHVE7JIG5GSZPIPXG6Y/2026-04-03T21:34:46.661Zalways0.5https://insights.citeline.com/resizer/-v7_P5SU53nwWnK4sqcczzfAmIo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4XMYET2HSZCP5AOVJ35DXGSZIM.jpghttps://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-five-ceos-and-six-cfos-among-this-weeks-changes-XO2PUC7F6VCLTBDSDIKGQSVPGM/2026-04-03T20:48:44.145Zalways0.5https://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/scrip/business/start-ups-and-smes/emerging-company-profiles/atrogi-bets-on-muscle-preservation-and-exercise-mimetics-to-drive-obesity-push-PFRWXHGOZZDSHOZFMU3V6KKK4M/2026-04-03T20:48:33.083Zalways0.5https://insights.citeline.com/resizer/nmhWke_dNwKh-0V862dJCec-fxU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NYNFF3DFPFG7BNH6Z2D7LDYGYE.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/lipocines-oral-formulation-of-zulresso-fails-postpartum-depression-trial-BXNVX4VGERGO3CN7PDP4Q2234Y/2026-04-03T20:48:15.266Zalways0.5https://insights.citeline.com/resizer/xRxSyUEFzzJ-AYDyZ2TAorFpQ-4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2AO5ASHXGNGNFJGOOFWHVAXXNE.jpghttps://insights.citeline.com/scrip/leadership/interviews/acadia-ceo-led-the-company-to-a-key-goal-in-a-challenging-year-for-biopharma-FEW7E57XUNCZRLEF3QONFTSSTE/2026-04-03T19:03:07.221Zalways0.5https://insights.citeline.com/resizer/akXvdyvxM4BR-7uY9gtIxiSmqrM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R4WPXJ5DPJEJ5H3MRMS7MT64EM.jpghttps://insights.citeline.com/medtech-insight/device-area/cardiology/no-evidence-of-benefit-two-trials-prompt-calls-to-end-routine-use-of-jjs-impella-heart-pump-37ZEBGDQWVBLFN3L74T2VIVIYI/2026-04-03T17:08:48.482Zalways0.5https://insights.citeline.com/resizer/sj0VZV4i_KSg3fQ1N-rWMn-7MOQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FWZW7DN4OJJT7J2HILMH6HJ3CY.jpghttps://insights.citeline.com/medtech-insight/device-area/diagnostics/cancer-biomarker-test-advertising-largely-ok-nad-says-HXBFNXV24VAHZEOOMZQBLFZAFA/2026-04-03T16:07:03.098Zalways0.5https://insights.citeline.com/resizer/rULZMrOhwT3w7FwfxFcbpasXSYg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CM4MRXNWHJEDXLG6ERZTVJVR3Q.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/washington-sleep-doctor-gets-year-in-prison-for-distributing-recalled-philips-cpap-bipap-devices-S4ZU2XBQEJFQ7FXXLKJOVCLFDU/2026-04-03T16:05:07.866Zalways0.5https://insights.citeline.com/resizer/NTkcvPspN1Zi-7L_X15WjqEcGLI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PEXJB6C3B5DEFNYKWE2C7OQZI4.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/biosimilar-streamlining-takes-a-further-step-forward-in-europe-LEIIFCCRP5FLBL3VLIXML4KMSQ/2026-04-03T15:00:20.01Zalways0.5https://insights.citeline.com/resizer/C-kDWasJ-L1HGRfgeEdrX5i4ufs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GGWTS7PAONOYDEX24WQYHJDXGI.jpghttps://insights.citeline.com/scrip/focus-on-asia/india/glenmark-reshapes-us-ryaltris-strategy-steps-away-from-hikma-tie-up-YBFR7VTMN5D3DEHUWFC5ESJY4U/2026-04-03T12:31:11.002Zalways0.5https://insights.citeline.com/resizer/aUm70AfUSbDhHToqlCXBDuuecbo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6MGGKUUGKNHS5JCGATCCMSVCRY.jpghttps://insights.citeline.com/generics-bulletin/policy-and-regulation/us-shields-generics-from-tariffs-amid-supply-chain-concerns-ODDONQOH7ZHQNHL7PU6L27WVLA/2026-04-03T12:30:48.421Zalways0.5https://insights.citeline.com/resizer/oP8RxwkGcOYz73TnDFwLTyQ3jPo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3ATMDC7KK5G3ZGTHFSUMBGIIOQ.jpghttps://insights.citeline.com/generics-bulletin/products/value-added-medicines/hyloris-warns-valacyclovir-launch-could-slip-into-2027-KTARLZEL4ZH7JBVUQ3NG35OUKA/2026-04-03T12:20:55.793Zalways0.5https://insights.citeline.com/resizer/nj_7Zl1YCXUNGv3c9ZQGfExGNpk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BKVZHPSE2BJLXBTQ6VC4TSW3KQ.jpghttps://insights.citeline.com/generics-bulletin/conferences/AAM/its-day-and-night-haruvi-on-how-the-aam-has-evolved-TYH3HIOGJFAFHBH6IG2VAPWY3I/2026-04-03T12:20:47.596Zalways0.5https://insights.citeline.com/resizer/DAofbbCF6Zf82OSvOnjDp0w1Qfs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YJ72AXDW5FA4HMSB24P5BSK5EI.jpghttps://insights.citeline.com/generics-bulletin/products/generics/gdufa-iv-us-fda-worries-about-revenue-shortfalls-industry-does-not-VMS7XAEE6JFOVFWAI2PDW66XKU/2026-04-03T12:20:05.428Zalways0.5https://insights.citeline.com/resizer/DEi-mGUVfRZCHCaUF3qvaRWDgpU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DIN4U7LDQJHMFDQG4MNLY2Q3OI.jpghttps://insights.citeline.com/pink-sheet/market-access/pricing-debate/us-mfn-policies-are-driving-the-need-for-better-rwe-RJHXUNM7ONGKPLXWL7NRYT6QDM/2026-04-03T07:50:19.622Zalways0.5https://insights.citeline.com/resizer/LFHAQkfynwSIQmWgJmxzRqB_Aek=/cloudfront-us-east-1.images.arcpublishing.com/norstella/D7QL477D3VD7BNOJMAZKBWAFL4.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/real-world-evidence/ema-explains-how-to-assess-quality-of-rwd-used-in-regulatory-submissions-IXY3AK4JZZD3ZOUJVGDF4MVIMQ/2026-04-03T07:49:25.328Zalways0.5https://insights.citeline.com/resizer/Ip8RIe2B6vfYQ0cZmTmO3_Hvz_g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZNRCT3XOQRAXDND5EIDZMRIDNY.jpghttps://insights.citeline.com/pink-sheet/product-reviews/approvals/us-fda-approval-output-still-not-showing-impact-of-departures-BKN4Y5NWYZDFFD64PTPPF3RLQE/2026-04-03T07:48:25.624Zalways0.5https://insights.citeline.com/resizer/ryTlR5XxEeA83LhLDNV9lt7lRgI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUVCWFNNOZF33IOO3GY3OR2NTY.jpghttps://insights.citeline.com/pink-sheet/market-access/government-payers/medicare/most-favored-nation-pricing-deals-demos-complicate-medicare-negotiation-prospects-T5CY44662NCBLCAQBHOZAEG5W4/2026-04-03T07:47:19.781Zalways0.5https://insights.citeline.com/resizer/1LBy2W4POv8hvqrhKDXdbEYz98A=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LU54HEVOBVDNDGROUYUC2TNWFI.jpghttps://insights.citeline.com/pink-sheet/policy-regulation/trump-100-tariffs-on-drugs-make-big-pharmas-negotiations-a-smart-play-LRD4YH2BYBH6LNVDMGHJDABJXY/2026-04-03T07:45:36.534Zalways0.5https://insights.citeline.com/resizer/4frB0frUOceiIp_pz4CA0t42xR8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/P4N2H3K6PNBQZARBE6GBKDABIU.jpghttps://insights.citeline.com/hbw-insight/wellness/business/strategy/us-consumer-health-people-news-primo-for-griffey-healthybaby-first-president-more-U2Z6Y52CURAMBAJ2HZY2YZMW6I/2026-04-03T02:39:18.69Zalways0.5https://insights.citeline.com/resizer/xEGZ8RolnGuKk0lVwfUen8aBAqU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KZETT2PWYRA3BOISCEGNHSK3BA.jpghttps://insights.citeline.com/hbw-insight/wellness/business/marketing-and-advertising/bayers-mens-pre-conception-health-multivitamin-ad-claims-fail-to-launch-in-nad-review-DUHPLGKSJVD3FEW2GMGAU7TCRQ/2026-04-03T02:37:55.256Zalways0.5https://insights.citeline.com/resizer/q0q-IQWcgOmXupDBLLRcAHTJz2U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/E5Y66DP2GVBZNPZPG3R4BFXVSI.jpghttps://insights.citeline.com/scrip/business/deals/lg-builds-global-oncology-ambitions-with-novel-frontier-asset-5OZSEYCDRNB3FJGEDMA5HRIT3M/2026-04-03T02:03:16.413Zalways0.5https://insights.citeline.com/resizer/E13o9gwW5Qa42baFU4COhzp8CbM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SCPJW7DJSZJORLDLJOUXAOXEQ4.jpghttps://insights.citeline.com/companies/renhe-yikang-group-co-ltd2026-04-03T00:08:05.325Zalways0.5https://insights.citeline.com/companies/cellio-therapeutics2026-04-03T00:07:35.325Zalways0.5https://insights.citeline.com/companies/kuraray-co-ltd2026-04-03T00:07:17.186Zalways0.5https://insights.citeline.com/companies/suzhou-aide-technology-development-co-ltd2026-04-03T00:07:11.314Zalways0.5https://insights.citeline.com/companies/view-point-medical-inc2026-04-03T00:07:05.49Zalways0.5https://insights.citeline.com/companies/eye-co-pty-ltd2026-04-03T00:06:59.224Zalways0.5https://insights.citeline.com/companies/shanghai-ddsome-laboratories-co-ltd2026-04-03T00:06:47.325Zalways0.5https://insights.citeline.com/companies/shanghai-guangsheng-pharmaceutical-co-ltd2026-04-03T00:06:40.985Zalways0.5https://insights.citeline.com/companies/i-lumen-scientific-inc2026-04-03T00:06:35.121Zalways0.5https://insights.citeline.com/companies/hangzhou-diagens-biotechnology-co-ltd2026-04-03T00:06:28.898Zalways0.5https://insights.citeline.com/companies/eth-zurich2026-04-03T00:06:23.078Zalways0.5https://insights.citeline.com/companies/subq-bionics-inc2026-04-03T00:06:16.95Zalways0.5https://insights.citeline.com/companies/korsana-biosciences2026-04-03T00:06:11.039Zalways0.5https://insights.citeline.com/companies/sdk-therapeutics-inc2026-04-03T00:06:05.078Zalways0.5https://insights.citeline.com/companies/beijing-genecradle-technology2026-04-03T00:05:58.959Zalways0.5https://insights.citeline.com/companies/lyncbio-therapeutics-coltd2026-04-03T00:05:52.837Zalways0.5https://insights.citeline.com/companies/ouro-medicines2026-04-03T00:05:46.989Zalways0.5https://insights.citeline.com/companies/laevoroc-chemotherapy2026-04-03T00:05:40.716Zalways0.5https://insights.citeline.com/companies/tippingpoint-biosciences2026-04-03T00:05:34.749Zalways0.5https://insights.citeline.com/companies/equilibra-bioscience2026-04-03T00:05:29.128Zalways0.5https://insights.citeline.com/companies/cuorips2026-04-03T00:05:22.801Zalways0.5https://insights.citeline.com/companies/laxxon-medical2026-04-03T00:05:16.821Zalways0.5https://insights.citeline.com/companies/neurosterix2026-04-03T00:05:10.54Zalways0.5https://insights.citeline.com/companies/tuhura-biosciences-inc2026-04-03T00:05:04.878Zalways0.5https://insights.citeline.com/companies/inhalerx-ltd2026-04-03T00:04:58.703Zalways0.5https://insights.citeline.com/companies/polyrizon-ltd2026-04-03T00:04:52.602Zalways0.5https://insights.citeline.com/companies/likang-life-sciences2026-04-03T00:04:46.444Zalways0.5https://insights.citeline.com/companies/transcend-therapeutics2026-04-03T00:04:40.648Zalways0.5https://insights.citeline.com/companies/terrestrial-bio-inc2026-04-03T00:04:34.311Zalways0.5https://insights.citeline.com/companies/imperative-care-inc2026-04-03T00:04:28.36Zalways0.5https://insights.citeline.com/companies/leucid-bio2026-04-03T00:04:22.414Zalways0.5https://insights.citeline.com/companies/centessa-pharmaceuticals-plc2026-04-03T00:04:16.317Zalways0.5https://insights.citeline.com/companies/biocytogen-pharmaceuticals-beijing-co-ltd2026-04-03T00:04:10.213Zalways0.5https://insights.citeline.com/companies/cigalah-group2026-04-03T00:04:04.345Zalways0.5https://insights.citeline.com/companies/ksq-therapeutics2026-04-03T00:03:58.31Zalways0.5https://insights.citeline.com/companies/galapagos-nv2026-04-03T00:03:52.18Zalways0.5https://insights.citeline.com/companies/leyden-laboratories-bv2026-04-03T00:03:46.089Zalways0.5https://insights.citeline.com/companies/kobe-university2026-04-03T00:03:40.009Zalways0.5https://insights.citeline.com/companies/katholieke-universiteit-leuven2026-04-03T00:03:34.028Zalways0.5https://insights.citeline.com/companies/salzman-group2026-04-03T00:03:28.083Zalways0.5https://insights.citeline.com/companies/jeol-ltd2026-04-03T00:03:24.105Zalways0.5https://insights.citeline.com/companies/klaria-pharma-holding-ab2026-04-03T00:03:16.074Zalways0.5https://insights.citeline.com/companies/sino-biopharmaceutical-limited2026-04-03T00:03:10.013Zalways0.5https://insights.citeline.com/companies/materialise2026-04-03T00:03:03.942Zalways0.5https://insights.citeline.com/companies/revance-therapeutics-inc2026-04-03T00:02:57.933Zalways0.5https://insights.citeline.com/companies/apple-inc2026-04-03T00:02:51.97Zalways0.5https://insights.citeline.com/companies/aurinia-pharmaceuticals-inc2026-04-03T00:02:45.91Zalways0.5https://insights.citeline.com/companies/bioatla-inc2026-04-03T00:02:39.771Zalways0.5https://insights.citeline.com/companies/algernon-health2026-04-03T00:02:33.786Zalways0.5https://insights.citeline.com/companies/yeda-research-development-co-ltd2026-04-03T00:02:21.763Zalways0.5https://insights.citeline.com/companies/alfresa-holdings-corporation2026-04-03T00:02:12.986Zalways0.5https://insights.citeline.com/companies/hoya-surgical-optics-inc2026-04-03T00:02:00.926Zalways0.5https://insights.citeline.com/companies/novartis-ag2026-04-03T00:01:48.751Zalways0.5https://insights.citeline.com/companies/oncolytics-biotech-inc2026-04-03T00:01:36.733Zalways0.5https://insights.citeline.com/companies/gilead-sciences-inc2026-04-03T00:01:25.305Zalways0.5